CSIMarket Company Name, Ticker, Customers, else..
 
Vyne Therapeutics Inc   (NASDAQ: VYNE)
 

Vyne Therapeutics Inc's Suppliers Performance

VYNE's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
VYNE Costs vs Sales of Suppliers Growth

• More on VYNE Suppliers






Vyne Therapeutics Inc's Comment on Supply Chain


The company utilizes third-party manufacturers and contract manufacturing organizations (CMOs) to supply raw materials, active ingredients, and finished products for preclinical studies and clinical trials. These CMOs adhere to FDA requirements, including Good Laboratory Practices (GLP) and current Good Manufacturing Practice (cGMP) guidelines. The company has agreements with Tay, comprising an Evaluation and Option Agreement and a License Agreement for Tay's BET inhibitor compounds. Under these agreements, Tay provides data packages and chemical entity candidates, while the company manages development, regulatory, marketing, and commercialization activities for the licensed products.

Vyne Therapeutics Inc's Comment on Supply Chain


The company utilizes third-party manufacturers and contract manufacturing organizations (CMOs) to supply raw materials, active ingredients, and finished products for preclinical studies and clinical trials. These CMOs adhere to FDA requirements, including Good Laboratory Practices (GLP) and current Good Manufacturing Practice (cGMP) guidelines. The company has agreements with Tay, comprising an Evaluation and Option Agreement and a License Agreement for Tay's BET inhibitor compounds. Under these agreements, Tay provides data packages and chemical entity candidates, while the company manages development, regulatory, marketing, and commercialization activities for the licensed products.







VYNE's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Vyne Therapeutics Inc 22.56 0.43 -12.31 10
SUBTOTAL 0.00 0.00 0.00 -


Sources: Vyne Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Vyne Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.